SKI Market

A+| A| A-|

Indian Indices

Sensex

76,802.90 -607.08
( -0.78%)

Global Indices

Nasdaq

51,585.70 72.15
(0.14%)

Dow Jones

7,521.58 80.48
(1.08%)

Hang Seng

70,971.12 -82.37
(-0.12%)

Nikkei 225

10,357.71 -41.99
(-0.40%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

338.0498657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

40.42

38263.41

EPS(TTM)

Face Value()

Div & Yield %

75.78

0.92

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	4845.92	4322.04	3971.12	3411.27	3140.64	2718.59
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	4845.92	4322.04	3971.12	3411.27	3140.64	2718.59
Other Income	204.40	119.87	116.48	132.75	139.73	103.57
Stock Adjustments	57.32	18.58	22.17	21.99	56.60	74.60
Total Income	5107.64	4460.49	4109.77	3566.01	3336.97	2896.76
EXPENDITURE :
Raw Materials	1134.58	1030.60	1101.59	1027.40	889.16	804.68
Power & Fuel Cost	73.17	70.22	66.44	65.53	54.09	43.42
Employee Cost	1194.05	1010.90	834.16	720.41	585.87	498.11
Other Manufacturing Expenses	223.18	198.94	168.11	185.50	169.95	119.25
Selling & Administrative Expenses	838.98	695.46	587.02	602.95	512.46	324.31
Miscellaneous Expenses	241.29	129.78	116.54	132.19	94.82	86.51
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	3705.25	3135.90	2873.86	2733.98	2306.35	1876.28
Operating Profit	1402.39	1324.59	1235.91	832.03	1030.62	1020.48
Interest	2.59	4.60	6.80	5.23	9.12	6.90
Gross Profit	1399.80	1319.99	1229.11	826.80	1021.50	1013.58
Depreciation	168.77	139.93	132.16	126.95	120.96	111.49
Profit Before Tax	1231.03	1180.06	1096.95	699.85	900.54	902.09
Tax	276.61	258.03	280.56	141.08	171.17	216.68
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	7.60	5.14	9.15	0.05	9.51	9.77
Reported Net Profit	946.82	916.89	807.24	558.72	719.86	675.64
Extraordinary Items	5.25	10.88	11.11	12.87	-0.62	2.91
Adjusted Net Profit	941.57	906.01	796.13	545.85	720.48	672.73
Adjustment below Net Profit	0.00	-213.11	-0.92	-74.72	-68.50	-32.42
P & L Balance brought forward	3607.47	3253.44	3089.29	2694.98	2125.83	1565.51
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	349.82	349.75	642.17	89.69	82.21	82.90
P & L Balance carried down	4204.47	3607.47	3253.44	3089.29	2694.98	2125.83
Dividend	349.82	349.75	642.17	89.69	82.21	82.90
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	1400.00	1400.00	2550.00	350.00	475.00	475.00
Dividend Per Share(Rs)	28.00	28.00	51.00	7.00	9.50	9.50
Earnings Per Share-Unit Curr	75.53	73.15	63.89	44.22	83.85	77.70
Earnings Per Share(Adj)-Unit Curr	75.53	73.15	63.89	44.22	55.90	51.80
Book Value-Unit Curr	336.94	289.21	270.17	256.94	369.15	331.80
Book Value(Adj)-Unit Curr	336.94	289.21	270.17	256.94	246.10	221.20

76,802.90 -607.08 ( -0.78%)

51,585.70 72.15 (0.14%)

7,521.58 80.48 (1.08%)

70,971.12 -82.37 (-0.12%)

10,357.71 -41.99 (-0.40%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)